TOP STORIES
respiratory
Pulmonary fibrosis

New details emerge on pulmonary adverse effects of low-dose MTX


A major trial has provided more details about the risk of lung injury with low dose methotrexate (MTX) and in particular for MTX-related pneumonitis. One of the largest studies ever of low dose methotrexate use – involving 2,391 people randomised to...

A major trial has provided more details about the risk of lung injury with low dose methotrexate (MTX) and in...

Read more